Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
NCT02525029
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
53
Enrollment
OTHER
Sponsor class
Conditions
Graft vs Host Disease
Interventions
DRUG:
Pregnyl®
Sponsor
Masonic Cancer Center, University of Minnesota